Publications
337 publications
Sort by: Date / Relevance
Extension of further conditions for SGLT2 inhibitors following recent GVS advice (22 June 2021)
Zorginstituut Nederland has completed its assessment whether the further conditions of SGLT-2 inhibitors canagliflozin ...
GVS advice roxadustat (Evrenzo®) for the treatment of symptomatic anaemia in chronic kidney damage
Zorginstituut Nederland has completed its assessment (using the CBG-ZIN parallel procedure) whether roxadustat (Evrenzo®) can be ...
Package advice ipilimumab (Yervoy®) in combination with nivolumab (Opdivo®)
Zorginstituut Nederland has completed its assessment whether ipilimumab (Yervoy®) in combination with nivolumab (Opdivo®) and two ...
GVS advice on the reassessment of tafamidis (Vyndaqel®)
The Zorginstituut recommends not to include tafamidis (Vyndaqel®) in the GVS, unless a price reduction of at least 50% can be ...
Advice on the reassessment of axicabtagene ciloleucel (Yescarta®)
Zorginstituut Nederland has carried out the reassessment of axicabtagene ciloleucel (Yescarta®).
GVS advice on ferrimaltol (Feraccru®) for treating iron deficiency
Zorginstituut Nederland recommends that ferrimaltol (Feraccru®) should not be included in the Medicine Reimbursement System ...
GVS advice on subcutaneous buprenorphine (Buvidal®)
Zorginstituut Nederland has completed its assessment whether the product subcutaneous buprenorphine (Buvidal®) is interchangeable ...
Package advice for the lock procedure drug betibeglogene autotemcel (Zynteglo®)
Zorginstituut Nederland has completed its assessment whether betibeglogene autotemcel (Zynteglo®) can be included in the insured ...
Package advice on avelumab (Bavencio®) for treating urothelial cell carcinoma
Zorginstituut Nederland has completed its assessment whether avelumab (Bavencio®) can be included in the insured package. ...
Package advice on entrectinib (Rozlytrek®) for the treatment of ROS1 fusion-positive advanced non-small cell lung cancer
Zorginstituut Nederland has completed its assessment whether entrectinib (Rozlytrek®) can be included in the insured package. The ...